OXFORD ONCO-THERAPEUTICS
Oxford Onco-Therapeutics is a personalized medicine startup that enables oncologists to predict the right treatment for each patient's specific cancer using a data-driven approach.
OXFORD ONCO-THERAPEUTICS
Industry:
Artificial Intelligence Health Care Medical Software
Founded:
2021-04-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Contact:
07517295306
Email Addresses:
[email protected]
Similar Organizations
EMMA.health
EMMA - your data driven personalised preventive healthcare coach.
SpeedCoder
Typing Practice for Programmers
More informations about "Oxford Onco-Therapeutics"
ONCOtherapeutics
We are a strategic Contract Research Organization (CRO) running multiple clinical trials in community oncology sites throughout the US. Uniquely focused on community-based …See details»
About • ONCOtherapeutics
We are a transformative strategic organization and preferred partner to our clients, leading to advanced drug development initiatives and the overall care for cancer patients. With more …See details»
Oxford onco-therapeutics | Bayes Centre - The University of …
Sep 30, 2024 Meet Oxford onco-therapeutics. Image. Problem. Current cancer treatment resembles a one-size-fits-all approach where most patients receive similar treatments without …See details»
Oxford Onco-Therapeutics - Products, Competitors, Financials, …
About Oxford Onco-Therapeutics. Oxford Onco-Therapeutics operates as a personalized medicine startup in Oncology. The company uses a combination of lab-based tests and …See details»
Who We Serve - ONCOtherapeutics
Industry & CROs. We provide high-quality deliverables to our partners who enjoy the benefits of our proactive, personal approach. Our comprehensive, personalized service portfolio can be …See details»
Oxford Onco-Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Oxford Onco-Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
OncoTherapeutics Company Profile 2024: Valuation, Investors ...
OncoTherapeutics General Information Description. Operator of a research organization intended to develop immunotherapeutic drugs. The company's research services focus on the …See details»
Oxford Onco-Therapeutics - Contacts, Employees, Board
Organization. Oxford Onco-Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Oxford Onco-Therapeutics Stock Price, Funding, Valuation, …
See Oxford Onco-Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Oxford Onco-Therapeutics's post-money valuation and revenue. …See details»
Entrepreneurship Centre at Oxford Saïd - Ashwin Nandakumar
Ashwin Nandakumar is one of the co-founders of Oxford Onco-Therapeutics and an I2I alumni. Oxford Onco-Therapeutics (OOT) is a personalized medicine start-up that enables oncologists …See details»
OTT | Empowering Oncology Innovation
Oxford Target Therapeutics is committed to pushing the boundaries of innovation by fostering multidisciplinary research collaborations. We actively engage with leading companies, …See details»
Oxford Onco-Therapeutics - Crunchbase
Oxford Onco-Therapeutics . Connect to CRM . SaveSee details»
Our Team - ONCOtherapeutics
Let’s discuss how our comprehensive clinical study management services can streamline the execution of your clinical trial, affecting greater cost savings and expediting the development …See details»
Oxford BioTherapeutics
Oxford BioTherapeutics (OBT) is a clinical stage oncology company focussed only on first-in-class immune therapies, with special emphasis on improving outcomes for patients with solid tumors …See details»
OGAP Discovery Platform - Oxford BioTherapeutics
OGAP® characterises cell surface protein expression of tumours and healthy tissue to identify novel cell-surface cancer targets to develop first-in-class antibody drug conjugate (ADC), …See details»
Industry & CROs • ONCOtherapeutics
Industry & CROs. We are a leading Contract Research Organization (CRO) that is designed to be an alternative to larger, conventional providers. We offer a comprehensive, personalized …See details»
Co-Founder @ Oxford Onco-Therapeutics - Crunchbase
Primary Organization . Oxford Onco-Therapeutics . Location Oxford, Oxfordshire, United Kingdom; Regions Europe, Middle East, and Africa (EMEA) Gender Male; LinkedIn View on …See details»
Onco Therapeutics - Begell House
Onco Therapeutics (OT) is an international journal that provides state-of-the-art authoritative reviews and research articles on selected topics in the emerging field of cancer therapeutics …See details»
The role of vorasidenib in the treatment of ... - Oxford Academic
Dec 25, 2024 J.R.W.: research funding from AnHeart Therapeutics to institute; received consulting fees from AnHeart Therapeutics and Servier; being on advisory boards for Roche …See details»
Nanobacterie - Crunchbase
Organization. Nanobacterie . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Ankrin Therapeutics is a biotechnology startup that develops drugs for …See details»